Slovensky (EUR)
Česky (CZK)
Magyar (HUF)
Slovenščina (EUR)
Deutsch (EUR)
04. Berberine and GLP‑1: What Studies Show and What We Still Don’t Know
Why does berberine feature in research on gut hormones? And what does it mean when scientists observe increased GLP‑1 release in the laboratory?
In this article, we examine selected original studies on berberine and GLP‑1. For each, we clearly identify the model used and what can be inferred for humans.
What is berberine?
Berberine is a plant alkaloid found, for example, in plants of the genus Berberis, commonly known as barberries. It is being studied in relation to several metabolic processes. One research question concerns its possible influence on the production and release of the gut hormone GLP‑1. [1, 4]
The words ‘being studied’ matter. Discovering a biological mechanism does not establish that a particular supplement will produce a predictable effect on hunger or body weight in humans.
What did the original studies show?
| Study | Research model | Main observation | What it does not establish |
|---|---|---|---|
| Yu et al., 2010 | Rats and the NCI‑H716 cell line. | Changes in GLP‑1 secretion and markers of its production. | An effect on satiety or weight loss in humans. |
| Yu et al., 2015 | The human NCI‑H716 cell line grown in the laboratory. | Involvement of the TAS2R38 receptor and PLC pathway in GLP‑1 release. | A clinical effect after people take berberine. |
| Sun et al., 2018 | Mice with diet-induced obesity and cell experiments. | An association between mitochondrial changes and restoration of GLP‑1 expression. | Restoration of intestinal cell function or weight regulation in humans. |
1. GLP‑1 production and release
In a study published in 2010, researchers administered berberine to rats and also investigated the NCI‑H716 cell line. They observed increased GLP‑1 secretion after a glucose challenge in animals and changes in the expression of proglucagon, from which GLP‑1 is produced. In cells, they also examined an enzyme involved in its processing. [1]
The results provide a basis for further research into hormone biosynthesis. However, they do not establish an effective human dose or demonstrate long-term appetite suppression.
2. Bitter taste receptors in intestinal cells
A 2015 study focused on the bitter taste receptor TAS2R38. Researchers investigated it in the NCI‑H716 cell line. Reducing its function decreased berberine-induced GLP‑1 release. The experiments also indicated involvement of the intracellular PLC pathway. [2]
‘Human cells’ does not mean ‘a human study’ here. Cells of human origin grown in the laboratory do not represent a whole organism with its digestion, metabolism and differing health conditions.
3. Mitochondria and the intestinal environment
Sun and colleagues studied mice with obesity induced by a high-fat diet. They observed mitochondrial stress changes in colonic cells associated with lower GLP‑1 expression. Berberine reduced these changes in the model studied. [3]
The study also examined gut microbiota and short-chain fatty acids. The authors considered direct and indirect mechanisms. However, this does not establish that berberine ‘repairs mitochondria’ in every person or increases GLP‑1 through the microbiome.
Why is a list of mechanisms not enough?
Receptors, gene expression and mitochondrial processes help explain what may happen in an experiment. A clinical study must separately establish whether an effect occurs in humans, how large it is, how long it lasts and what risks it involves.
What do we know about berberine and weight loss in humans?
The US National Center for Complementary and Integrative Health (NCCIH) states that some studies suggest a possible effect on weight, but the evidence is inconclusive. It highlights differences in preparations and populations studied, as well as methodological weaknesses in several studies. [4]
Even if a study finds weight loss or a change in blood glucose, without appropriate measurements we cannot claim that GLP‑1 caused the result. The mechanism of action is a separate research question.
Why is the term ‘nature’s Ozempic’ misleading?
This comparison suggests a comparable effect. However, the preclinical studies described did not compare berberine with semaglutide treatment in humans and do not establish that it is interchangeable with medicines.
Nor can they establish that berberine is automatically safer simply because it comes from plants.
Safety and medicine interactions
Berberine can cause nausea, abdominal pain, bloating, constipation or diarrhoea. It may also affect medicines; an interaction with cyclosporine, for example, has been documented. [4]
It should be avoided during pregnancy and breastfeeding and should not be given to infants. If you take medicines or have a health concern, discuss its suitability with a doctor or pharmacist. This article does not specify a dosage. [4, 5]
Frequently asked questions
Does berberine increase GLP‑1?
This effect was observed in the cited cell and animal experiments. However, these findings alone do not establish a reliable clinical effect in humans. [1–3]
Do these studies demonstrate hunger suppression?
No. Observing a change in hormone secretion in the laboratory is not evidence of reduced hunger, lower food intake or long-term weight loss in humans.
Is berberine a replacement for diabetes or obesity medicines?
The research described does not support this conclusion. Do not change prescribed treatment on the basis of an article about a supplement’s mechanisms.
What does AMPK mean in berberine research?
AMPK is an enzyme complex involved in regulating cellular energy metabolism. Its involvement was also investigated using an inhibitor in the 2010 study. This is not direct evidence of ‘speeding up metabolism’ or weight loss in humans. [1]
Does plant origin guarantee safety?
No. Plant substances can also have adverse effects and interactions. Medicines taken and individual health status are therefore important when considering berberine. [4, 5]
Simply put
Berberine and GLP‑1 represent an interesting area of preclinical research. Bitter taste receptors, hormone biosynthesis and mitochondrial processes offer possible explanations. However, establishing an effect in humans requires high-quality clinical trials.
Continue to article 05: Chromium and L-carnitine →Curious about what’s in food supplements?
Our Nutraceuticals Buying Guide lets you compare ingredients across the KINGRAY range and check the amounts per daily dose and any precautions for use.
Educational purpose: This article does not replace diagnosis or treatment and does not recommend a specific product. Experimental findings cannot automatically be attributed to dietary supplements available on the market.
